NO20074723L - Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjon - Google Patents
Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjonInfo
- Publication number
- NO20074723L NO20074723L NO20074723A NO20074723A NO20074723L NO 20074723 L NO20074723 L NO 20074723L NO 20074723 A NO20074723 A NO 20074723A NO 20074723 A NO20074723 A NO 20074723A NO 20074723 L NO20074723 L NO 20074723L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- group
- antifungal
- useful
- fungal infection
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 239000003429 antifungal agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 5
- 206010017533 Fungal infection Diseases 0.000 abstract 4
- 208000031888 Mycoses Diseases 0.000 abstract 4
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 2
- 125000000320 amidine group Chemical group 0.000 abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000017520 skin disease Diseases 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 230000001861 immunosuppressant effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Farmasøytisk preparat inneholdende én eller flere antisoppmidler valgt fra et arylamidinderivat representert ved den generelle formel: [Kjemisk Formel 1] (hvor R1 representerer en amidino-gruppe som kan være substituert med en hydroksylgruppe som kan beskyttes med en acylgruppe, en amidin-gruppe som kan være substituert med en alkoksygruppe som kan være substituert eller en amidin-gruppe som kan være substituert med en aralkyloksygruppe som kan være substituert; R2 og R3 like eller forskjellige representerer et hydrogenatom eller et halogenatom) eller et salt derav, et azol antisoppmiddel, et polyen antisoppmiddel, et candin antisoppmiddel og et fluorpyrimidin antisoppmiddel har en sterk antisopp aktivitet og er anvendelige for behandling av soppinfeksjon. En metode for anvendelse av dem i kombinasjon er anvendelige som en utmerket terapeutisk metode for soppinfeksjon. Farmasøytisk preparat inneholdende arylamidinderivatet representert ved kjemisk formel 1 eller et salt derav og et immunosuppressivt middel har en sterk antisopp aktivitet og er anvendelige for behandling av soppinfeksjon og en hudsykdom så som atopisk dermatitt. En metode for anvendelse av dem i kombinasjon er anvendelig som en utmerket terapeutisk metode for soppinfeksjon og en hudsykdom så som atopisk dermatitt.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005110784 | 2005-04-07 | ||
| PCT/JP2006/307204 WO2006109642A1 (ja) | 2005-04-07 | 2006-04-05 | 医薬組成物および抗真菌剤を組み合わせて使用する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20074723L true NO20074723L (no) | 2007-12-28 |
| NO339713B1 NO339713B1 (no) | 2017-01-23 |
Family
ID=37086920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074723A NO339713B1 (no) | 2005-04-07 | 2007-09-17 | Arylamidinderivater og farmasøytisk preparat inneholdende samme for anvendelse i soppmidler i kombinasjon |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8993603B2 (no) |
| EP (1) | EP1867332B1 (no) |
| JP (1) | JP5216323B2 (no) |
| KR (1) | KR101325620B1 (no) |
| CN (1) | CN101151032B (no) |
| AU (1) | AU2006234228B2 (no) |
| BR (1) | BRPI0607910A2 (no) |
| CA (1) | CA2602121C (no) |
| CY (1) | CY1111983T1 (no) |
| DK (1) | DK1867332T3 (no) |
| ES (1) | ES2368078T3 (no) |
| NO (1) | NO339713B1 (no) |
| NZ (1) | NZ561675A (no) |
| PL (1) | PL1867332T3 (no) |
| PT (1) | PT1867332E (no) |
| RU (1) | RU2396955C2 (no) |
| SI (1) | SI1867332T1 (no) |
| WO (1) | WO2006109642A1 (no) |
| ZA (1) | ZA200708530B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006264649A1 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
| ZA200805604B (en) * | 2005-12-29 | 2009-12-30 | Toyama Chemical Co Ltd | Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| JP5132569B2 (ja) * | 2006-10-06 | 2013-01-30 | 富山化学工業株式会社 | フェニルアミジン誘導体を含有する医薬組成物および抗真菌剤を組み合わせて使用する方法 |
| WO2012043701A1 (ja) * | 2010-09-30 | 2012-04-05 | 富山化学工業株式会社 | 経皮吸収製剤 |
| EP2723452A2 (en) | 2011-06-22 | 2014-04-30 | Vyome Biosciences Pvt Ltd | Conjugate-based antifungal and antibacterial prodrugs |
| WO2014195872A1 (en) | 2013-06-04 | 2014-12-11 | Vyome Biosciences Pvt. Ltd. | Coated particles and compositions comprising same |
| KR101658365B1 (ko) | 2015-06-10 | 2016-09-22 | 주식회사 케어사이드 | 피부 감염의 예방 및 치료용 조성물 |
| CN109689028A (zh) * | 2016-07-12 | 2019-04-26 | 马丁尼斯生物制药纳米技术公司 | 用于中枢神经系统递送和治疗隐球菌感染的脂质卷包封的抗真菌化合物 |
| WO2019118527A1 (en) * | 2017-12-14 | 2019-06-20 | The Johns Hopkins University | Novel anti-fungal inhibitors |
| CN110269939A (zh) * | 2019-03-12 | 2019-09-24 | 武汉愔紫生物科技有限公司 | 一种治疗真菌分泌蛋白介导的炎症疾病标志物的药物、药物组合物、用途及其使用方法 |
| KR102978287B1 (ko) * | 2019-07-11 | 2026-06-17 | 가부시키가이샤 세렌 파머 | 프로토테카증의 신규 치료제 |
| CN115768517B (zh) | 2020-06-03 | 2024-08-16 | 石原产业株式会社 | 非人类动物用抗菌剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2939292A1 (de) * | 1979-09-28 | 1981-04-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| JP2865722B2 (ja) | 1989-08-14 | 1999-03-08 | 日産自動車株式会社 | カチオン電着塗料組成物 |
| JPH03288051A (ja) | 1990-03-30 | 1991-12-18 | Mazda Motor Corp | カムシャフトおよびその製造方法 |
| GB9509631D0 (en) | 1995-05-12 | 1995-07-05 | Sandoz Ltd | Antifungal combination |
| ES2203819T3 (es) | 1996-09-12 | 2004-04-16 | MERCK & CO., INC. | Terapia antifungica combinada. |
| AUPQ066399A0 (en) | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
| DK1481966T3 (da) * | 2002-03-06 | 2011-10-24 | Toyama Chemical Co Ltd | Nyt arylamidinderivat eller salt deraf |
| JP4937506B2 (ja) * | 2003-09-05 | 2012-05-23 | 富山化学工業株式会社 | 新規なアリールアミジン誘導体またはその塩 |
| JP4885722B2 (ja) * | 2004-06-30 | 2012-02-29 | 富山化学工業株式会社 | 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤 |
-
2006
- 2006-04-05 SI SI200631142T patent/SI1867332T1/sl unknown
- 2006-04-05 ES ES06731152T patent/ES2368078T3/es not_active Expired - Lifetime
- 2006-04-05 PT PT06731152T patent/PT1867332E/pt unknown
- 2006-04-05 BR BRPI0607910-5A patent/BRPI0607910A2/pt not_active Application Discontinuation
- 2006-04-05 US US11/910,999 patent/US8993603B2/en active Active
- 2006-04-05 DK DK06731152.2T patent/DK1867332T3/da active
- 2006-04-05 CN CN2006800106796A patent/CN101151032B/zh not_active Expired - Fee Related
- 2006-04-05 JP JP2007512933A patent/JP5216323B2/ja not_active Expired - Lifetime
- 2006-04-05 CA CA2602121A patent/CA2602121C/en not_active Expired - Lifetime
- 2006-04-05 PL PL06731152T patent/PL1867332T3/pl unknown
- 2006-04-05 KR KR1020077024236A patent/KR101325620B1/ko not_active Expired - Fee Related
- 2006-04-05 WO PCT/JP2006/307204 patent/WO2006109642A1/ja not_active Ceased
- 2006-04-05 EP EP06731152A patent/EP1867332B1/en not_active Expired - Lifetime
- 2006-04-05 AU AU2006234228A patent/AU2006234228B2/en not_active Ceased
- 2006-04-05 RU RU2007141162/15A patent/RU2396955C2/ru active
- 2006-04-05 ZA ZA200708530A patent/ZA200708530B/xx unknown
- 2006-04-05 NZ NZ561675A patent/NZ561675A/en unknown
-
2007
- 2007-09-17 NO NO20074723A patent/NO339713B1/no unknown
-
2011
- 2011-08-30 CY CY20111100835T patent/CY1111983T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2368078T3 (es) | 2011-11-14 |
| JP5216323B2 (ja) | 2013-06-19 |
| CA2602121C (en) | 2014-09-23 |
| CA2602121A1 (en) | 2006-10-19 |
| US8993603B2 (en) | 2015-03-31 |
| NZ561675A (en) | 2010-07-30 |
| WO2006109642A1 (ja) | 2006-10-19 |
| CN101151032A (zh) | 2008-03-26 |
| KR101325620B1 (ko) | 2013-11-06 |
| EP1867332A4 (en) | 2010-01-27 |
| BRPI0607910A2 (pt) | 2010-03-23 |
| SI1867332T1 (sl) | 2011-11-30 |
| EP1867332A1 (en) | 2007-12-19 |
| AU2006234228B2 (en) | 2011-05-26 |
| PT1867332E (pt) | 2011-11-03 |
| KR20080002854A (ko) | 2008-01-04 |
| EP1867332B1 (en) | 2011-08-24 |
| PL1867332T3 (pl) | 2012-01-31 |
| RU2396955C2 (ru) | 2010-08-20 |
| NO339713B1 (no) | 2017-01-23 |
| ZA200708530B (en) | 2009-04-29 |
| DK1867332T3 (da) | 2011-09-19 |
| US20090087480A1 (en) | 2009-04-02 |
| JPWO2006109642A1 (ja) | 2008-11-13 |
| RU2007141162A (ru) | 2009-05-20 |
| CY1111983T1 (el) | 2015-11-04 |
| CN101151032B (zh) | 2011-06-22 |
| AU2006234228A1 (en) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062726L (no) | Nye pyridazin-3(2H)-on derivater | |
| NO20070432L (no) | Pyrimidinureaderivater som kinaseinhibitorer | |
| NO20071246L (no) | Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer. | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| NO20073719L (no) | Kjemiske forbindelser | |
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| WO2008016738A3 (en) | Antibacterial agents and related screening methods using small molecule macroarrays | |
| NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav | |
| NO20084872L (no) | 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig | |
| NO20082709L (no) | Kjemiske forbindelser | |
| NO20084845L (no) | 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig | |
| NO20055688L (no) | Organiske forbindelser | |
| UA95796C2 (ru) | Производные n-циклопропил-бензиламида, способ их получения, фунгицидная композиция и способ борьбы с фитопатогенными грибами | |
| NO20071109L (no) | Indol-2-karboksamidinderivater som NMDA-reseptorantagonister | |
| NO20083542L (no) | Nye kumarinderivater med antitumoraktivitet | |
| NO20054220L (no) | Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
| NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
| NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
| NO20061743L (no) | Kinazolinderivater | |
| NO20081217L (no) | Nye benzotiazolonderivater | |
| NO20076357L (no) | Azabicykliske heterocykler som cannabinoid reseptor modulatorer | |
| WO2009016218A3 (en) | Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: FUJIFILM TOYAMA CHEMICAL CO., JP |
|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: APPILI THERAPEUTICS INC., CA |